AMERICAN HEALTHCARE REIT INC SEC Filings

American Healthcare REIT (AHR) filed a Form 144 notice for a proposed sale of 20,010 shares of common stock. The filing lists an aggregate market value of $994,105, to be transacted through Merrill, with the NYSE named as the exchange and an approximate sale date of 11/10/2025. Shares outstanding were 176,908,238.

The shares to be sold were acquired via restricted stock vesting on several dates, including 10/01/2023 (5,762), 06/15/2024 (3,025), 10/01/2024 (5,762), 02/09/2025 (1,851), and 11/07/2025 (3,610).

American Healthcare REIT, Inc. (AHR) reported a profitable Q3 2025. Total revenues were $572,937,000, up from $523,814,000 a year ago, driven by resident fees and services of $532,058,000. Net income attributable to controlling interest was $55,927,000, or $0.33 per basic and diluted share, compared with a loss in the prior-year quarter.

Expenses rose with property operating costs at $454,530,000 and depreciation and amortization at $49,181,000. Other items included an impairment of real estate investments of $3,768,000 and a gain on re-measurement of a previously held equity interest of $14,580,000. Interest expense, net improved to $20,392,000 from $30,395,000.

For the nine months, operating cash flow reached $239,276,000. The company executed acquisitions totaling $337,978,000 (15 properties) and dispositions of $56,454,000 (12 assets). Cash and cash equivalents increased to $147,364,000, while lines of credit and term loan, net declined to $549,696,000. Shares outstanding were 171,031,062 as of September 30, 2025; 176,908,238 were outstanding as of November 3, 2025.

American Healthcare REIT, Inc. (AHR) furnished an 8-K announcing its quarterly disclosures. The company released its earnings press release for the quarter ended September 30, 2025 and issued a Q3 2025 supplemental package.

The materials are provided under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD). Exhibits include 99.1 (Earnings Release) and 99.2 (Third Quarter 2025 Supplemental). The information in Items 2.02 and 7.01 is being furnished, not filed.

Mark E. Foster, EVP, GC & Secretary of American Healthcare REIT, Inc. (AHR), reported the sale of 3,850 shares of the company's common stock on 09/03/2025 at an average price of $41.8887 per share, with transaction prices ranging from $41.84 to $41.92. After the sale, the reporting person beneficially owned 59,100 shares. The ownership total includes 1,059 shares newly acquired under the issuer's Employee Stock Purchase Plan, as disclosed in the form.

The filing is a Section 16 Form 4 reporting a non-derivative disposition by a company officer. The report includes an undertaking to provide, upon request, a breakdown of the number of shares sold at each separate price. No derivative transactions, amendments, or additional material terms are disclosed in this submission.

Form 144 filed for American Healthcare REIT, Inc. (AHR) reports a proposed sale of 3,850 shares of common stock with an aggregate market value of $161,271.00. The filing lists 168,575,204 shares outstanding and an approximate sale date of 09/03/2025 on the NYSE through Merrill (8890 Lyra Dr, Columbus, OH). The securities to be sold were acquired as restricted stock that vested on 08/26/2024 (1,242 shares) and 09/03/2024 (2,608 shares), both from American Healthcare REIT, Inc. The filer indicates no securities sold in the past three months and includes the required representation about absence of undisclosed material adverse information.

Principal Real Estate Investors, LLC and Principal Global Investors jointly report beneficial ownership of 9,622,200 shares of American Healthcare REIT, Inc. (AHR), representing 6.0% of the outstanding class. The filing breaks ownership down as 8,505,227 shares (5.3%) held with shared voting and dispositive power by Principal Real Estate Investors and 1,116,973 shares (0.7%) held with shared voting and dispositive power by Principal Global Investors. Both reporting persons indicate no sole voting or dispositive power and classify themselves as an IA (investment adviser).

The filing includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

American Healthcare REIT, Inc. (NYSE: AHR) filed a prospectus supplement establishing an “at-the-market” equity program to offer up to $1,000,000,000 of common stock. Shares may be sold through appointed agents or via forward sale agreements; physical settlement would yield net proceeds equal to the forward price times shares, while cash or net-share settlement could result in no proceeds or require payments or share deliveries. The stock closed at $39.86 on August 7, 2025. Net proceeds are intended to be contributed to the Operating Partnership for OP Units and used for general corporate purposes, including repayment of indebtedness; as of June 30, 2025 there were no outstanding revolver borrowings under the Credit Facility (matures Feb 14, 2028). The prospectus highlights dilution risk, forward-settlement acceleration and tax uncertainty related to cash settlements of forward agreements.

American Healthcare REIT, Inc. (AHR) reported rising operating revenue and a return to quarterly profit driven by resident fees. Total revenues were $542,503,000 for the three months ended June 30, 2025, up from $504,581,000 a year earlier; resident fees and services increased to $501,285,000. Net income for the quarter was $10,079,000 versus $2,926,000 in Q2 2024, producing basic earnings per share of $0.06 versus $0.01. Cash and cash equivalents rose to $133,494,000 and combined cash, cash equivalents and restricted cash were $169,991,000 at period end. The company recorded impairment charges of $12,659,000 in the quarter and $34,365,000 year-to-date related to certain outpatient medical buildings. Mortgage debt outstanding was $983,510,000 and borrowings under the 2024 Credit Facility totaled $550,000,000 (approximately $549,632,000 net). During the period AHR completed property acquisitions and dispositions, issued common equity under ATM and follow-on programs, and declared distributions totaling $0.50 per share for the six months.